What is Oxy-Gen?
Oxy-Gen operates at the intersection of animal husbandry and performance science, specializing in the development of high-efficacy supplements for livestock, including equine, rabbits, and bucking bulls. The company distinguishes itself through deep collaboration with industry experts to engineer formulations that optimize animal health and competitive performance. By targeting the niche market of breeders and livestock owners who prioritize excellence in show and event environments, Oxy-Gen has established a reputation for building champions. Their product suite is designed to meet the rigorous demands of high-stakes animal husbandry, ensuring that performance metrics are met through scientifically backed nutritional support.
How much funding has Oxy-Gen raised?
Oxy-Gen has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Oxy-Gen
PPP
Public-Private Partnership
What's next for Oxy-Gen?
With the recent infusion of capital, Oxy-Gen is poised to scale its operational capabilities and broaden its research and development initiatives. The company is expected to focus on enhancing its distribution networks and potentially diversifying its product portfolio to address emerging needs in the animal performance market. As it transitions through this late-stage growth phase, the strategic deployment of these funds will likely center on market penetration and the strengthening of its competitive moat against traditional supplement providers. Investors will be monitoring the firm's ability to maintain its high standards of product efficacy while scaling to meet the demands of a global livestock market.
See full Oxy-Gen company page
